A decade of comparative dose planning studies for early-stage hodgkin lymphoma: What can we learn?

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 5, 2014, Pages 1126-1135

  Maraldo, Maja V ^a   Specht, Lena ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLOGY; RADIATION EFFECTS; RADIOTHERAPY; RISK PERCEPTION;

COMBINED MODALITY TREATMENT; DELIVERY TECHNIQUES; DOSE DISTRIBUTIONS; ORGANS AT RISKS; PATIENT ANATOMY; PATIENT POPULATION; PLAN EVALUATION; STANDARD OF CARES;

DISEASE CONTROL;

CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; HODGKIN DISEASE; HUMAN; LIFE EXPECTANCY; PATIENT CARE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION HAZARD; REVIEW; TREATMENT PLANNING; INTENSITY MODULATED RADIATION THERAPY; MULTIMODALITY CANCER THERAPY; NEOPLASMS, SECOND PRIMARY; ORGANS AT RISK; PATHOLOGY; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; TIME;

COMBINED MODALITY THERAPY; HODGKIN DISEASE; HUMANS; LYMPHATIC IRRADIATION; NEOPLASMS, SECOND PRIMARY; ORGANS AT RISK; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TIME FACTORS;

EID: 84919956524     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.06.069     Document Type: Review

References (66)

1. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
2. A. Engert, A. Plutschow, and H.T. Eich Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
3. B.M. Aleman, A.W. van den Belt-Dusebout, and W.J. Klokman Long-term cause-specific mortality of patients treated for Hodgkin's disease J Clin Oncol 21 2003 3431 3439
4. S.M. Castellino, A.M. Geiger, and A.C. Mertens Morbidity and mortality in long-term survivors of Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study Blood 117 2011 1806 1816
5. A.K. Ng, M.P. Bernardo, and E. Weller Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101 2108
6. M.B. Lund, J. Kongerud, and O. Nome Lung function impairment in long-term survivors of Hodgkin's disease Ann Oncol 6 1995 495 501
7. A.K. Ng, S. Li, and D. Neuberg A prospective study of pulmonary function in Hodgkin's lymphoma patients Ann Oncol 19 2008 1754 1758
8. B.M. Aleman, A.W. van den Belt-Dusebout, and M.L. De Bruin Late cardiotoxicity after treatment for Hodgkin lymphoma Blood 109 2007 1878 1886
9. S.L. Hancock, S.S. Donaldson, and R.T. Hoppe Cardiac disease following treatment of Hodgkin's disease in children and adolescents J Clin Oncol 11 1993 1208 1215
10. G. Schellong, M. Riepenhausen, and C. Bruch Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies Pediatr Blood Cancer 55 2010 1145 1152
11. D.C. Bowers, D.E. McNeil, and Y. Liu Stroke as a late treatment effect of Hodgkin's disease: A report from the Childhood Cancer Survivor Study J Clin Oncol 23 2005 6508 6515
12. M.L. De Bruin, L.D. Dorresteijn, and M.B. van't Veer Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma J Natl Cancer Inst 101 2009 928 937
13. L.S. Constine, S.S. Donaldson, and I.R. McDougall Thyroid dysfunction after radiotherapy in children with Hodgkin's disease Cancer 53 1984 878 883
14. S.L. Hancock, R.S. Cox, and I.R. McDougall Thyroid diseases after treatment of Hodgkin's disease N Engl J Med 325 1991 599 605
15. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949 1955
16. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors Blood 100 2002 1989 1996
17. Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, version 5.3 (25.04.2013). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu, accessed on August 28, 2013.
18. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, 2013. Accessed on August 28, 2013.
19. C. Herbst, F.A. Rehan, and N. Skoetz Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma Cochrane Database Syst Rev 2011 CD007110
20. A. Engert, P. Schiller, and A. Josting Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3601 3608
21. C. Ferme, H. Eghbali, and J.H. Meerwaldt Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease N Engl J Med 357 2007 1916 1927
22. S.A. Rosenberg, and H.S. Kaplan Evidence for an orderly progression in the spread of Hodgkin's disease Cancer Res 26 1966 1225 1231
23. T. Girinsky, R. van der Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277
24. T. Girinsky, L. Specht, and M. Ghalibafian The conundrum of Hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
25. L. Specht, J. Yahalom, and T. Illidge Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG) Int J Radiat Oncol Biol Phys 89 2014 854 862
26. A.Y. Jorgensen, M.V. Maraldo, and N.P. Brodin The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma Acta Oncol 52 2013 1559 1565
27. E.S. Koh, T.H. Tran, and M. Heydarian A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk Radiat Oncol 2 2007 13
28. M.V. Maraldo, N.P. Brodin, and M.C. Aznar Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy Radiother Oncol 110 2014 441 447
29. M.V. Maraldo, P. Brodin, and M.C. Aznar Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: Is stroke still a late effect of treatment? Int J Radiat Oncol Biol Phys 87 2013 297 303
30. M.V. Maraldo, N.P. Brodin, and M.C. Aznar Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Ann Oncol 24 2013 2113 2118
31. M.V. Maraldo, M. Jorgensen, and N.P. Brodin The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma Pediatr Blood Cancer 61 2014 717 722
32. M.V. Maraldo, N.P. Brodin, and I.R. Vogelius Risk of developing cardiovascular disease after involved-node radiotherapy versus mantle field for Hodgkin lymphoma Int J Radiat Oncol Biol Phys 83 2012 1232 1237
33. A. Ng, K.K. Brock, and M.B. Sharpe Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: A step toward understanding dose risk for late toxicity Int J Radiat Oncol Biol Phys 84 2012 e557 e563
34. D. Vordermark, I. Seufert, and F. Schwab 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: Doses to cardiac structures Radiat Oncol 1 2006 10
35. D.L. Andolino, T. Hoene, and L. Xiao Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients Int J Radiat Oncol Biol Phys 81 2011 e667 e671
36. B.A. Campbell, C. Hornby, and J. Cunninghame Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapy Ann Oncol 23 2012 1259 1266
37. L. Cella, R. Liuzzi, and M. Magliulo Radiotherapy of large target volumes in Hodgkin's lymphoma: Normal tissue sparing capability of forward IMRT versus conventional techniques Radiat Oncol 5 2010 33
38. L. Cella, M. Conson, and M.C. Pressello Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms Radiat Oncol 8 2013 22 0
39. X. Chen, D. Jin, and S. Wang Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma J Appl Clin Med Phys 13 2012 3769
40. B.S. Dabaja, N.C.S. Rebueno, and A. Mazloom Radiation for Hodgkin's lymphoma in young female patients: A new technique to avoid the breasts and decrease the dose to the heart Int J Radiat Oncol Biol Phys 79 2011 503 507
41. V. De Sanctis, C. Bolzan, and M. D'Arienzo Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy? Radiat Oncol 7 2012 129
42. T. Girinsky, C. Pichenot, and A. Beaudre Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64 2006 218 226
43. K.A. Goodman, S. Toner, and M. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
44. J. Koeck, Y. Abo-Madyan, and F. Lohr Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): The roles of intensity-modulated radiotherapy and involved-node radiotherapy Int J Radiat Oncol Biol Phys 83 2012 268 276
45. N.N. Lu, Y.X. Li, and R.Y. Wu Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement Int J Radiat Oncol Biol Phys 84 2012 210 216
46. D.C. Weber, N. Peguret, and G. Dipasquale Involved-node and involved-field volumetric modulated arc vs fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: A comparative planning study Int J Radiat Oncol Biol Phys 75 2009 1578 1586
47. D. Antoni, S. Natarajan-Ame, and P. Meyer Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease Radiat Oncol 8 2013 112
48. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
49. C. Fiandra, A.R. Filippi, and P. Catuzzo Different IMRT solutions vs 3D-conformal radiotherapy in early stage Hodgkin's lymphoma: Dosimetric comparison and clinical considerations Radiat Oncol 7 2012 186
50. B.S. Hoppe, S. Flampouri, and Z. Su Consolidative Involved-Node Proton Therapy for Stage IA-IIIB Mediastinal Hodgkin lymphoma: Preliminary dosimetric outcomes from a phase II study Int J Radiat Oncol Biol Phys 83 2012 260 267
51. B.S. Hoppe, S. Flampouri, and Z. Su Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma Int J Radiat Oncol Biol Phys 84 2012 449 455
52. J. Li, B. Dabaja, and V. Reed Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma Int J Radiat Oncol Biol Phys 81 2011 167 174
53. A. Paumier, M. Ghalibafian, and A. Beaudre Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma Int J Radiat Oncol Biol Phys 80 2011 199 205
54. A. Paumier, M. Ghalibafian, and J. Gilmore Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 82 2012 1522 1527
55. D.C. Weber, S. Johanson, and N. Peguret Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients Int J Radiat Oncol Biol Phys 81 2011 490 497
56. K. Behringer, A. Josting, and P. Schiller Solid tumors in patients treated for Hodgkin's disease: A report from the German Hodgkin Lymphoma Study Group Ann Oncol 15 2004 1079 1085
57. M.L. De Bruin, J. Sparidans, and M.B. van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
58. S. Sasse, B. Klimm, and H. Gorgen Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma Ann Oncol 23 2012 2953 2959
59. J. Franklin, A. Pluetschow, and M. Paus Second malignancy risk associated with treatment of Hodgkin's lymphoma: Meta-analysis of the randomised trials Ann Oncol 17 2006 1749 1760
60. B.A. Campbell, N. Voss, and T. Pickles Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: A question of field size J Clin Oncol 26 2008 5170 5174
61. A.R. Filippi, P. Ciammella, and C. Piva Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma Int J Radiat Oncol Biol Phys 89 2014 370 375
62. M.V. Maraldo, M.C. Aznar, and I.R. Vogelius Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma Int J Radiat Oncol Biol Phys 85 2013 1057 1065
63. U. Schneider, A. Lomax, and N. Lombriser Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation Radiat Res 154 2000 382 388
64. D.C. Hodgson, E.S. Koh, and T.H. Tran Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma Cancer 110 2007 2576 2586
65. A.R. Filippi, R. Ragona, and M. Fusella Changes in breast cancer risk associated with different volumes, doses and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiotherapy Pract Radiat Oncol 3 2013 216 222
66. N.P. Brodin, M.V. Maraldo, and M.C. Aznar Interactive decision-support tool for risk-based radiation therapy plan comparison for Hodgkin lymphoma Int J Radiat Oncol Biol Phys 88 2014 433 445